Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.38 USD -1.3% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Wall Street
Price Targets

AUPH Price Targets Summary
Aurinia Pharmaceuticals Inc

Wall Street analysts forecast AUPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AUPH is 9.97 USD with a low forecast of 6.06 USD and a high forecast of 13.65 USD.

Lowest
Price Target
6.06 USD
28% Downside
Average
Price Target
9.97 USD
19% Upside
Highest
Price Target
13.65 USD
63% Upside

AUPH Last Price Targets
Aurinia Pharmaceuticals Inc

The latest public price target was made on Sep 6, 2024 by Ed Arce from H.C. Wainwright , who expects AUPH stock to rise by 55% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Ed Arce
H.C. Wainwright
13 USD
Upside 55%
2 months ago
Sep 6, 2024
H.C. Wainwright Reiterates Buy Rating on Aurinia Pharmaceuticals (AUPH)
StreetInsider
Maury Raycroft
Jefferies
6 USD
Downside 28%
6 months ago
May 2, 2024
Aurinia Pharmaceuticals (AUPH) PT Lowered to $6 at Jefferies
StreetInsider
Ed Arce
H.C. Wainwright
Price Target 13 USD
Upside/Downside 55%
View Source
Maury Raycroft
Jefferies
Price Target 6 USD
Upside/Downside 28%
View Source
Aurinia Pharmaceuticals Inc Competitors:
Price Targets
PBYI
Puma Biotechnology Inc
38% Upside
GNS
Genus PLC
44% Upside
ALNY
Alnylam Pharmaceuticals Inc
14% Upside
ARWR
Arrowhead Pharmaceuticals Inc
124% Upside
BCYC
Bicycle Therapeutics PLC
71% Upside
BEAM
Beam Therapeutics Inc
78% Upside
BVXP
Bioventix PLC
52% Upside
NIOX
Niox Group PLC
31% Upside

Revenue
Forecast

Revenue Estimate
Aurinia Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Aurinia Pharmaceuticals Inc's revenue is 133%. The projected CAGR for the next 3 years is 26%.

133%
Past Growth
26%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Aurinia Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Aurinia Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AUPH's stock price target?
Price Target
9.97 USD

According to Wall Street analysts, the average 1-year price target for AUPH is 9.97 USD with a low forecast of 6.06 USD and a high forecast of 13.65 USD.

What is Aurinia Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
26%

For the last 8 years the compound annual growth rate for Aurinia Pharmaceuticals Inc's revenue is 133%. The projected CAGR for the next 3 years is 26%.

Back to Top